Cargando…
Androgen receptor overexpression in prostate cancer in type 2 diabetes
OBJECTIVE: While prostate cancer does not occur more often in men with diabetes, survival is markedly reduced in this patient group. Androgen signaling is a known and major driver for prostate cancer progression. Therefore, we analyzed major components of the androgen signaling chain and cell prolif...
Autores principales: | Lutz, Stefan Zoltán, Hennenlotter, Jörg, Scharpf, Marcus Oliver, Sailer, Corinna, Fritsche, Louise, Schmid, Vera, Kantartzis, Konstantinos, Wagner, Robert, Lehmann, Rainer, Berti, Lucia, Peter, Andreas, Staiger, Harald, Fritsche, Andreas, Fend, Falko, Todenhöfer, Tilman, Stenzl, Arnulf, Häring, Hans-Ulrich, Heni, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985051/ https://www.ncbi.nlm.nih.gov/pubmed/29249638 http://dx.doi.org/10.1016/j.molmet.2017.11.013 |
Ejemplares similares
-
Diabetes and the Prostate: Elevated Fasting Glucose, Insulin Resistance and Higher Levels of Adrenal Steroids in Prostate Cancer
por: Lutz, Stefan Zoltán, et al.
Publicado: (2022) -
Insulin Receptor Isoforms A and B as well as Insulin Receptor Substrates-1 and -2 Are Differentially Expressed in Prostate Cancer
por: Heni, Martin, et al.
Publicado: (2012) -
Differential Expression and Clinical Relevance of C-X-C Motif Chemokine Receptor 4 (CXCR4) in Renal Cell Carcinomas, Benign Renal Tumors, and Metastases
por: Maas, Moritz, et al.
Publicado: (2023) -
Utility of pT3 substaging in lymph node-negative urothelial carcinoma of the bladder: do pathologic parameters add to prognostic sub-stratification?
por: Maas, Moritz, et al.
Publicado: (2021) -
FTO Genotype Interacts with Improvement in Aerobic Fitness on Body Weight Loss During Lifestyle Intervention
por: Sailer, Corinna, et al.
Publicado: (2016)